Voyager Therapeutics, Inc. (VYGR) Return on equity 2016–2025
Voyager Therapeutics, Inc. (VYGR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-61.1%FY2025 · since FY2016: -29.6% → -61.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -61.1% | -39.4 pp |
| FY2024 | -21.7% | -77.7 pp |
| FY2023 | 56.0% | +134.6 pp |
| FY2022 | -78.6% | -3.7 pp |
| FY2021 | -74.9% | -98.7 pp |
| FY2020 | 23.8% | +67.6 pp |
| FY2019 | -43.8% | +146.3 pp |
| FY2018 | -190.1% | -137.3 pp |
| FY2017 | -52.7% | -23.2 pp |
| FY2016 | -29.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice